Katarzyna Kobusińska

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

Gerd Horneff, Rubén Burgos‐Vargas, Tamás Constantin et al. · Annals of the Rheumatic Diseases · 2013 · 137 citations · Full text

Life Sciences, Genetics, Microbiology +17

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Ivan Foeldvari, Tamás Constantin, Jelena Vojinović et al. · Arthritis Research & Therapy · 2019 · 46 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +15

Etanercept treatment in juvenile idiopathic arthritis: The Polish registry

Zbigniew Żuber, Lidia Rutkowska‐Sak, Jacek Postępski et al. · Medical Science Monitor · 2011 · 29 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Clinical remission in juvenile idiopathic arthritis after termination of etanercept

Jacek Postępski, Katarzyna Kobusińska, Edyta Olesińska et al. · Rheumatology International · 2012 · 25 citations · Full text

Medicine, Pharmacotherapy, Pediatric Immunology +7

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study

Hermine I. Brunner, Jonathan Akikusa, Eslam Al‐Abadi et al. · Annals of the Rheumatic Diseases · 2024 · 22 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +6